{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:49:03Z","timestamp":1794023343908,"version":"4.8.0"},"reference-count":213,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T00:00:00Z","timestamp":1420502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jcmgh.2014.12.008","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T07:33:16Z","timestamp":1421047996000},"page":"131-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology"],"prefix":"10.1016","volume":"1","author":[{"given":"Mark","family":"Kidd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irvin M.","family":"Modlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bodei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignat","family":"Drozdov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2014.12.008_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11864-013-0246-4","article-title":"Evolving treatment strategies for management of carcinoid tumors","volume":"14","author":"Strosberg","year":"2013","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.bpg.2013.01.008","article-title":"Intervention in gastro-enteropancreatic neuroendocrine tumours","volume":"26","author":"Baudin","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib4","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib5","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib6","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/ajg.2010.341","article-title":"Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971","volume":"105","author":"Ellis","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.sla.0000129342.67174.67","article-title":"Updated population-based review of carcinoid tumors","volume":"240","author":"Maggard","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/jnci\/djn275","article-title":"Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors","volume":"100","author":"Modlin","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4419-0857-5_16","article-title":"Multiple endocrine neoplasia type 1: clinical manifestations and management","volume":"153","author":"Powell","year":"2010","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib11","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1530\/ERC-13-0365","article-title":"Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art","volume":"21","author":"de Mestier","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminoncol.2012.11.013","article-title":"The evolving landscape of neuroendocrine tumors","volume":"40","author":"Bergsland","year":"2013","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib13","first-page":"143","article-title":"Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway","volume":"24","author":"Wang","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000342270","article-title":"Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead","volume":"96","author":"Sundin","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib15","first-page":"15","article-title":"EGFR\/TGF\u03b1 and TGF\u03b2\/CTGF signaling in neuroendocrine neoplasia: theoretical therapeutic targets","volume":"15","author":"Kidd","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11864-011-0148-2","article-title":"New treatment options for patients with advanced neuroendocrine tumors","volume":"12","author":"Chan","year":"2011","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/j.seminoncol.2010.10.014","article-title":"Pancreatic endocrine tumors","volume":"37","author":"Oberg","year":"2010","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib18","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/annonc\/mdq022","article-title":"Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)","volume":"21","author":"Garcia-Carbonero","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000197899","article-title":"Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut","volume":"89","author":"Strosberg","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib20","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1530\/ERC-12-0024","article-title":"Neuroendocrine tumor disease: an evolving landscape","volume":"19","author":"Frilling","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib21","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S1470-2045(13)70362-0","article-title":"Recommendations for management of patients with neuroendocrine liver metastases","volume":"15","author":"Frilling","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.soc.2006.05.002","article-title":"Carcinoid tumors","volume":"15","author":"Sippel","year":"2006","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2011-300831","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)","volume":"61","author":"Ramage","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4329\/wjr.v5.i6.241","article-title":"Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy?","volume":"5","author":"Neperud","year":"2013","journal-title":"World J Radiol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib26","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1016\/j.ejrad.2013.06.017","article-title":"Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors","volume":"82","author":"Denecke","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/annonc\/mdh216","article-title":"Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system","volume":"15","author":"Oberg","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib29","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib30","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.2007.13.6374","article-title":"Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b","volume":"26","author":"Yao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib31","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.gtc.2010.08.013","article-title":"New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors","volume":"39","author":"Lawrence","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib34","doi-asserted-by":"crossref","first-page":"e65166","DOI":"10.1371\/journal.pone.0065166","article-title":"Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysis","volume":"8","author":"Qi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1634\/theoncologist.2012-0434","article-title":"Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learned","volume":"18","author":"Yao","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000096050","article-title":"Friedrich Feyrter: a precise intellect in a diffuse system","volume":"83","author":"Champaneria","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/bjc.1975.242","article-title":"Cancer and ageing in mice and men","volume":"32","author":"Peto","year":"1975","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib38","series-title":"Dynamics of cancer: incidence, inheritance, and evolution","author":"Frank","year":"2007"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib39","first-page":"322","article-title":"Carcinoid tumours. Frequency in a defined population during a 12-year period","volume":"84","author":"Berge","year":"1976","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CCO.0b013e3282f1c595","article-title":"Neuroendocrine tumors of the diffuse neuroendocrine system","volume":"20","author":"Gustafsson","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10699-012-9294-7","article-title":"The unexpected applicability of paraconsistent logic: a Chomskyan route to dialetheism","volume":"18","author":"McGinnis","year":"2013","journal-title":"Found Sci"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1196\/annals.1294.002","article-title":"The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification","volume":"1014","author":"Kloppel","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.gastro.2009.01.005","article-title":"Delineation of the chemomechanosensory regulation of gastrin secretion using pure rodent G cells","volume":"137","author":"Kidd","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/00365520500331281","article-title":"A\u00a0new method for visualization of gut mucosal cells, describing the enterochromaffin cell in the rat gastrointestinal tract","volume":"41","author":"Gustafsson","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1752-8062.2011.00299.x","article-title":"Axon-like basal processes in\u00a0enteroendocrine cells: characteristics and potential targets","volume":"4","author":"Bohorquez","year":"2011","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2982.2008.01210.x","article-title":"IL1\u03b2- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn\u2019s disease","volume":"21","author":"Kidd","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2826.2007.01578.x","article-title":"Long slender cytoplasmic extensions: a common feature of neuroendocrine cells?","volume":"19","author":"Hauso","year":"2007","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib48","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1002\/cncr.26592","article-title":"The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms","volume":"118","author":"Schimmack","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1677\/erc.0.0100459","article-title":"The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut","volume":"10","author":"Ardill","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib50","doi-asserted-by":"crossref","first-page":"G260","DOI":"10.1152\/ajpgi.00056.2008","article-title":"Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants","volume":"295","author":"Kidd","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s001090050261","article-title":"Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system","volume":"76","author":"Wiedenmann","year":"1998","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib52","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1079\/PNS19780037","article-title":"Gut hormones","volume":"37","author":"Bloom","year":"1978","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib53","series-title":"Gut hormones","author":"Bloom","year":"1978"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib54","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1245\/s10434-010-1006-3","article-title":"Chromogranin A\u2014biological function and clinical utility in neuro endocrine tumor disease","volume":"17","author":"Modlin","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib55","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1034\/j.1600-0854.2002.30706.x","article-title":"SNAP-25 and synaptotagmin 1 function in Ca2+-dependent reversible docking of granules to the plasma membrane","volume":"3","author":"Chieregatti","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/002215540104900408","article-title":"Selective processing of chromogranin A in the different islet cells in human pancreas","volume":"49","author":"Portela-Gomes","year":"2001","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3109\/1354750X.2012.654511","article-title":"Limitations of chromogranin A in clinical practice","volume":"17","author":"Marotta","year":"2012","journal-title":"Biomarkers"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib58","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bpg.2012.12.006","article-title":"Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs)","volume":"26","author":"Kanakis","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ecl.2010.12.001","article-title":"The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib60","doi-asserted-by":"crossref","first-page":"e81111","DOI":"10.1371\/journal.pone.0081111","article-title":"Chromogranin A and its fragments as regulators of small intestinal neuroendocrine neoplasm proliferation","volume":"8","author":"Giovinazzo","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib61","first-page":"G607","article-title":"G\u00a0protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: an exemplary family","volume":"274","author":"Wank","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib62","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ceca.2011.12.002","article-title":"Calcium dynamics in the secretory granules of neuroendocrine cells","volume":"51","author":"Alvarez","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-90-481-3271-3_7","article-title":"Electrophysiology of islet cells","volume":"654","author":"Drews","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPA.0b013e3182a71537","article-title":"Expression of glucagon-like peptide 1 receptor and its effects on biologic behavior in pancreatic neuroendocrine tumors","volume":"43","author":"Cases","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.npep.2008.05.001","article-title":"Differential activation of enkephalin, galanin, somatostatin, NPY, and VIP neuropeptide production by stimulators of protein kinases A and C in neuroendocrine chromaffin cells","volume":"42","author":"Hook","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.molbrainres.2004.04.006","article-title":"Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) in the rat frontal cortex but not in the hippocampus","volume":"126","author":"Garcia-Osta","year":"2004","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib67","doi-asserted-by":"crossref","first-page":"G397","DOI":"10.1152\/ajpgi.00087.2011","article-title":"The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion","volume":"302","author":"Chin","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib68","doi-asserted-by":"crossref","first-page":"19143","DOI":"10.1523\/JNEUROSCI.2634-13.2013","article-title":"Secretagogue stimulation of neurosecretory cells elicits filopodial extensions uncovering new functional release sites","volume":"33","author":"Papadopulos","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib69","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.tips.2013.10.001","article-title":"Illuminating somatostatin analog action at neuroendocrine tumor receptors","volume":"34","author":"Reubi","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib70","first-page":"859","article-title":"Somatostatin acts by inhibiting the cyclic 3\u2019,5\u2019-adenosine monophosphate (cAMP)\/protein kinase A pathway, cAMP response element-binding protein (CREB) phosphorylation, and CREB transcription potency","volume":"11","author":"Tentler","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib71","doi-asserted-by":"crossref","first-page":"31667","DOI":"10.1074\/jbc.M102613200","article-title":"Regulation of L-type calcium channels in pituitary GH4C1 cells by depolarization","volume":"276","author":"Peri","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.physiol.63.1.49","article-title":"Gastrin, CCK, signaling, and cancer","volume":"63","author":"Rozengurt","year":"2001","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib73","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cellsig.2006.09.001","article-title":"The duration of ERK1\/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1","volume":"19","author":"Chalmers","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/MCB.19.1.321","article-title":"Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis","volume":"19","author":"Treinies","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0016-5085(98)70369-5","article-title":"Comparison of the signal transduction pathways activated by gastrin in enterochromaffin-like and parietal cells","volume":"115","author":"Kinoshita","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib76","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MOG.0b013e328358d5b9","article-title":"Proton pump inhibitors: potential adverse effects","volume":"28","author":"Abraham","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11894-010-0158-4","article-title":"A\u00a0clinical perspective on gastric neuroendocrine neoplasia","volume":"13","author":"Lawrence","year":"2011","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib78","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1210\/jc.2007-2279","article-title":"A\u00a0prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors","volume":"93","author":"Berna","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib79","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1158\/1078-0432.CCR-04-1915","article-title":"Increased expression of insulin-like growth factor I and\/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases","volume":"11","author":"Furukawa","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib80","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/cncr.22725","article-title":"Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-\u03b21-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1","volume":"109","author":"Kidd","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib81","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/modpathol.3800427","article-title":"Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas","volume":"18","author":"Papouchado","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib82","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1365-2362.1998.00397.x","article-title":"Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours","volume":"28","author":"Wulbrand","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib83","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.2910600514","article-title":"Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours","volume":"60","author":"Nilsson","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib84","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1677\/ERC-09-0318","article-title":"Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors","volume":"17","author":"Gilbert","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib85","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000478-199703000-00009","article-title":"Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids","volume":"21","author":"Krishnamurthy","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib86","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/annonc\/mdl105","article-title":"Rationale for the use of somatostatin analogs as antitumor agents","volume":"17","author":"Susini","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib87","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yfrne.2013.07.005","article-title":"Somatostatin receptors: from signaling to clinical practice","volume":"34","author":"Theodoropoulou","year":"2013","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib88","first-page":"161","article-title":"The expanding role of somatostatin analogs in the management of neuroendocrine tumors","volume":"5","author":"Wolin","year":"2012","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib89","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ydbio.2012.08.023","article-title":"Notch signaling differentially regulates the cell fate of early endocrine precursor cells and their maturing descendants in the mouse pancreas and intestine","volume":"371","author":"Li","year":"2012","journal-title":"Dev Biol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib90","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1210\/jc.2005-0540","article-title":"Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling","volume":"90","author":"Nakakura","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib91","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1677\/ERC-07-0108","article-title":"Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum","volume":"14","author":"Fendrich","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib92","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.4161\/cbt.5.11.3458","article-title":"Sonic Hedgehog-Gli1 signaling pathway might become an effective therapeutic target in gastrointestinal neuroendocrine carcinomas","volume":"5","author":"Shida","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib93","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1530\/ERC-10-0153","article-title":"Src kinase activity coordinates cell adhesion and spreading with activation of mammalian target of rapamycin in pancreatic endocrine tumour cells","volume":"18","author":"Di Florio","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib94","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR Signaling in Cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib95","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1541-7786.MCR-13-0224-T","article-title":"BRAFV600E cooperates with PI3K signaling, independent of Akt, to regulate melanoma cell proliferation","volume":"12","author":"Silva","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib96","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1002\/cncr.26011","article-title":"Limitations in small intestinal neuroendocrine tumor therapy by mTOR kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1\/2 and Akt","volume":"117","author":"Svejda","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib97","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","article-title":"Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance","volume":"13","author":"Rozengurt","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib98","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1309\/YQBR9C05RU4DD3RN","article-title":"BRAF gene mutations are rare events in gastroenteropancreatic neuroendocrine tumors","volume":"123","author":"Tannapfel","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib99","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1677\/erc.1.00841","article-title":"BRAF and endocrine tumors: mutations are frequent in papillary thyroid carcinomas, rare in endocrine tumors of the gastrointestinal tract and not detected in other endocrine tumors","volume":"11","author":"Perren","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000100508","article-title":"Rap1\/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target","volume":"85","author":"Karhoff","year":"2007","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00129039-200206000-00008","article-title":"Differential expression of the PTEN tumor suppressor protein in fetal and adult neuroendocrine tissues and tumors: progressive loss of PTEN expression in poorly differentiated neuroendocrine neoplasms","volume":"10","author":"Wang","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib102","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2826.2006.01425.x","article-title":"Epidermal growth factor receptor expression and activation in neuroendocrine tumours","volume":"18","author":"Shah","year":"2006","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jcp.52.5.321","article-title":"Cell proliferation in gastrointestinal mucosa","volume":"52","author":"Wong","year":"1999","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib104","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF00202885","article-title":"Islet cell neogenesis in the pancreas","volume":"427","author":"Bouwens","year":"1996","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib106","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib107","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature10275","article-title":"A\u00a0continuum model for tumour suppression","volume":"476","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib108","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/eva.12025","article-title":"Peto\u2019s paradox revisited: theoretical evolutionary dynamics of cancer in wild populations","volume":"6","author":"Roche","year":"2013","journal-title":"Evol Appl"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib109","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","article-title":"Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib110","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1210\/jc.2003-031575","article-title":"Non-islet origin of pancreatic islet cell tumors","volume":"89","author":"Vortmeyer","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib111","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2005.06.002","article-title":"Endocrine tumours of the pancreas","volume":"19","author":"Oberg","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.jcmgh.2014.12.008_bib112","first-page":"S135","article-title":"Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract","volume":"31","author":"Rindi","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib113","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1349-7006.1992.tb02722.x","article-title":"ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism","volume":"83","author":"Yoshimoto","year":"1992","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib114","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1172\/JCI69004","article-title":"Menin determines K-RAS proliferative outputs in endocrine cells","volume":"124","author":"Chamberlain","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1677\/erc.0.0100437","article-title":"Genetics of neuroendocrine and carcinoid tumours","volume":"10","author":"Leotlela","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib116","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jnci\/djt135","article-title":"Current understanding of the molecular biology of pancreatic neuroendocrine tumors","volume":"105","author":"Zhang","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib117","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib118","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/ncomms3810","article-title":"Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1","volume":"4","author":"Cao","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib119","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S1740925X08000057","article-title":"Events at the transition between cell cycle exit and oligodendrocyte progenitor differentiation: the role of HDAC and YY1","volume":"3","author":"He","year":"2007","journal-title":"Neuron Glia Biol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib120","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0002-9440(10)65495-8","article-title":"Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization","volume":"155","author":"Speel","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib121","first-page":"5186","article-title":"Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas","volume":"61","author":"Speel","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib122","first-page":"285","article-title":"High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications","volume":"61","author":"Rigaud","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib123","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/gcc.1201","article-title":"Genomic imbalances in the progression of endocrine pancreatic tumors","volume":"32","author":"Zhao","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib124","first-page":"4373","article-title":"Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors","volume":"85","author":"Chung","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib125","first-page":"3706","article-title":"Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors","volume":"58","author":"Chung","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib126","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0002-9440(10)64624-X","article-title":"Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells","volume":"157","author":"Perren","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib127","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1200\/JCO.2008.21.5988","article-title":"Pancreatic endocrine tumors: expression profiling evidences a role for Akt-mTOR pathway","volume":"28","author":"Missiaglia","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1947601910371979","article-title":"Gene amplifications in well-differentiated pancreatic neuroendocrine tumors inactivate the p53 pathway","volume":"1","author":"Hu","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib129","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/modpathol.3800353","article-title":"Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors","volume":"18","author":"D\u2019Adda","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib130","first-page":"361","article-title":"Microsatellite instability and allelic losses in neuroendocrine tumors of the gastro-entero-pancreatic system","volume":"15","author":"Ghimenti","year":"1999","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib131","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1196\/annals.1294.023","article-title":"Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system","volume":"1014","author":"Arnold","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib132","first-page":"15","article-title":"The genomic landscape of small intestine neuroendocrine tumors","author":"Banck","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib133","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Francis","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib134","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/modpathol.2010.223","article-title":"Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMP","volume":"24","author":"Warth","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/cncr.20750","article-title":"Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors","volume":"103","author":"Kidd","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib136","first-page":"781","article-title":"Multiple endocrine neoplasia syndromes associated with mutation of p27","volume":"36","author":"Lee","year":"2013","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib137","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1073\/pnas.0503484102","article-title":"Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c","volume":"102","author":"Karnik","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib138","unstructured":"Vijayvergia N, Boland P, Gustafson K, et\u00a0al. Molecular profiling of advanced stage neuroendocrine tumors (NETs): the Fox Chase Cancer Center (FCCC) experience. Poster presented at the 2015 Gastrointestinal Cancers Symposium, San Francisco, Jan 15-17, 2015; abstract 245; NANETs Abstract Handbook 2014, abstract BT13. Available at: http:\/\/meetinglibrary.asco.org\/content\/139139-158."},{"key":"10.1016\/j.jcmgh.2014.12.008_bib139","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/gut.48.4.536","article-title":"Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation","volume":"48","author":"Tonnies","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib140","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64136-3","article-title":"Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids","volume":"158","author":"Kytola","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib141","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/gcc.10081","article-title":"Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas","volume":"34","author":"Kytola","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib142","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ijc.1276","article-title":"Chromosome 18 deletions are common events in classical midgut carcinoid tumors","volume":"92","author":"Lollgen","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib143","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1677\/ERC-09-0052","article-title":"High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids","volume":"16","author":"Andersson","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib144","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/gcc.20561","article-title":"High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss","volume":"47","author":"Kulke","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib145","first-page":"3","article-title":"The deleted in colorectal cancer (DCC) gene: a candidate tumour suppressor gene encoding a cell surface protein with similarity to neural cell adhesion molecules","volume":"24","author":"Fearon","year":"1995","journal-title":"Cancer Surv"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib146","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00428-004-1052-y","article-title":"Analysis of chromosome-11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridization-based study","volume":"445","author":"Petzmann","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib147","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1677\/ERC-10-0248","article-title":"A\u00a0pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum","volume":"18","author":"Walsh","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib148","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1023\/A:1005560428937","article-title":"Combination analysis of genetic alterations and cell proliferation in small intestinal carcinomas","volume":"45","author":"Muneyuki","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib149","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/cncr.11197","article-title":"Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine","volume":"97","author":"Planck","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1245\/ASO.2004.03.077","article-title":"Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies","volume":"11","author":"Bloomston","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib151","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/ERC-07-0194","article-title":"Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis","volume":"15","author":"Duerr","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib152","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1245\/ASO.2006.12.011","article-title":"The role of genetic markers\u2014NAP1L1, MAGE-D2, and MTA1\u2014in defining small-intestinal carcinoid neoplasia","volume":"13","author":"Kidd","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib153","doi-asserted-by":"crossref","first-page":"989","DOI":"10.5858\/2006-130-989-CAOTEO","article-title":"Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue","volume":"130","author":"Hofer","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib154","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/cncr.24180","article-title":"Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning","volume":"115","author":"Drozdov","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/modpathol.2008.174","article-title":"Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas","volume":"22","author":"Leja","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib156","doi-asserted-by":"crossref","first-page":"e16010","DOI":"10.1371\/journal.pone.0016010","article-title":"Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors","volume":"5","author":"Cui","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib157","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1530\/ERC-10-0256","article-title":"Different gene expression profiles in metastasizing midgut carcinoid tumors","volume":"18","author":"Edfeldt","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib158","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2164-15-595","article-title":"Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors","volume":"15","author":"Kidd","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib159","doi-asserted-by":"crossref","first-page":"e22457","DOI":"10.1371\/journal.pone.0022457","article-title":"Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia","volume":"6","author":"Drozdov","year":"2011","journal-title":"PloS ONE"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib160","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1200\/JCO.2005.05.5194","article-title":"MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior","volume":"24","author":"Roldo","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib161","first-page":"2249","article-title":"Global MicroRNA profiling of pancreatic neuroendocrine neoplasias","volume":"34","author":"Thorns","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib162","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1158\/1078-0432.CCR-12-3092","article-title":"MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls","volume":"19","author":"Li","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib163","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/modpathol.2012.216","article-title":"Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors","volume":"26","author":"Li","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib164","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/modpathol.2009.161","article-title":"MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression","volume":"23","author":"Ruebel","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000299790","article-title":"First report on metastasizing small bowel carcinoids in first-degree relatives in three generations","volume":"91","author":"Jarhult","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib166","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/332085a0","article-title":"Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma","volume":"332","author":"Larsson","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib167","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1158\/0008-5472.CAN-10-1887","article-title":"Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells","volume":"70","author":"Boissan","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib168","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-2005-870152","article-title":"Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast","volume":"37","author":"Hendy","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib169","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1158\/1541-7786.MCR-13-0170","article-title":"Menin directly represses Gli1 expression independent of canonical Hedgehog signaling","volume":"11","author":"Gurung","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib170","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1038\/cddis.2013.98","article-title":"Menin mediates epigenetic regulation via histone H3 lysine 9 methylation","volume":"4","author":"Yang","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib171","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib172","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tibs.2013.05.005","article-title":"Menin: a scaffold protein that controls gene expression and cell signaling","volume":"38","author":"Matkar","year":"2013","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib173","first-page":"452","article-title":"Maladie de von Hippel-Lindau: progr\u00e8s g\u00e9n\u00e9tiques r\u00e9cents et prise en charge des patients. [Von Hippel-Lindau disease: recent genetic progress and patient management.] Francophone Study Group of von Hippel-Lindau Disease (GEFVH)","volume":"59","author":"Richard","year":"1998","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib174","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","article-title":"Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C","volume":"269","author":"Kibel","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-5793(03)01392-9","article-title":"Fibronectin is a hypoxia-independent target of the tumor suppressor VHL","volume":"556","author":"Bluyssen","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib176","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s100720050017","article-title":"The neurofibromatoses. An overview","volume":"20","author":"Ruggieri","year":"1999","journal-title":"Ital J Neurol Sci"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib177","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/08830738040190091101","article-title":"Molecular genetic basis of tuberous sclerosis complex: from bench to bedside","volume":"19","author":"Au","year":"2004","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib178","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/cncr.21451","article-title":"The molecular genetics of gastroenteropancreatic neuroendocrine tumors","volume":"104","author":"Zikusoka","year":"2005","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jcmgh.2014.12.008_bib179","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000051850","article-title":"Molecular genetics of neuroendocrine tumors","volume":"62","author":"Calender","year":"2000","journal-title":"Digestion"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib180","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/annonc\/mdn706","article-title":"Familial gastrointestinal carcinoid tumours and associated cancers","volume":"20","author":"Hiripi","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib181","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.1473","article-title":"Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiologic study from Sweden","volume":"94","author":"Hemminki","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib182","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/1055-9965.EPI-07-0750","article-title":"Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study","volume":"17","author":"Hassan","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib183","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/jmcb\/mjs048","article-title":"Activation of the ATM-Snail pathway promotes breast cancer metastasis","volume":"4","author":"Sun","year":"2012","journal-title":"J\u00a0Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib184","doi-asserted-by":"crossref","first-page":"e34456","DOI":"10.1371\/journal.pone.0034456","article-title":"Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the ATM gene","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib185","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s13277-012-0420-5","article-title":"Prognostic significance of ATM and cyclin B1 in pancreatic neuroendocrine tumor","volume":"33","author":"Shin","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib186","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1158\/0008-5472.CAN-11-2345","article-title":"Metastasis-associated protein 1\/nucleosome remodeling and histone deacetylase complex in cancer","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib187","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00428-011-1069-y","article-title":"Involvement of HER-2\/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors","volume":"458","author":"Azzoni","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib188","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bpg.2012.12.004","article-title":"Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours","volume":"26","author":"Sundin","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib189","first-page":"551","article-title":"Somatostatin receptors in human endocrine tumors","volume":"47","author":"Reubi","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib190","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/bjc.1998.101","article-title":"Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours","volume":"77","author":"Nilsson","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib191","doi-asserted-by":"crossref","DOI":"10.1159\/000367850","article-title":"The status of neuroendocrine tumor imaging: from darkness to light?","author":"Bodei","year":"2014","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib192","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/211598a0","article-title":"5-hydroxytryptophan uptake by dog thyroid \u2018C\u2019 cells, and its possible significance in polypeptide hormone production","volume":"211","author":"Pearse","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib193","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1158\/0008-5472.CAN-08-0095","article-title":"Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-l-phenylalanine accumulation in neuroendocrine tumor cells","volume":"68","author":"Neels","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib194","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1469-7793.2001.0605h.x","article-title":"Measurement of secretory vesicle pH reveals intravesicular alkalinization by vesicular monoamine transporter type 2 resulting in inhibition of prohormone cleavage","volume":"531","author":"Blackmore","year":"2001","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib195","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/sj.bjc.6601276","article-title":"Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters","volume":"89","author":"Kolby","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib196","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.semnuclmed.2012.01.002","article-title":"Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms","volume":"42","author":"Baum","year":"2012","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib197","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1470-2045(06)70801-4","article-title":"Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study","volume":"7","author":"Koopmans","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib198","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1210\/jc.2004-1938","article-title":"Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography","volume":"90","author":"Orlefors","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib199","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1158\/1078-0432.CCR-09-1759","article-title":"18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors","volume":"16","author":"Binderup","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11523-012-0225-x","article-title":"Inhibition of mTOR in carcinoid tumors","volume":"7","author":"Grozinsky-Glasberg","year":"2012","journal-title":"Target Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib201","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4155\/fmc.13.214","article-title":"Challenges and opportunities in targeting the menin-MLL interaction","volume":"6","author":"Cierpicki","year":"2014","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib202","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1182\/blood-2012-05-429274","article-title":"Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia","volume":"120","author":"Shi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/0008-5472.CAN-10-2651","article-title":"TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases","volume":"71","author":"Mohammad","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib204","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nm.2610","article-title":"Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL","volume":"18","author":"Della Gatta","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib205","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1182\/blood-2010-08-301556","article-title":"Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes","volume":"117","author":"Piccaluga","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib206","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1245\/s10434-008-0251-1","article-title":"Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors","volume":"16","author":"Modlin","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"Suppl","key":"10.1016\/j.jcmgh.2014.12.008_bib207","doi-asserted-by":"crossref","first-page":"A4137","DOI":"10.1200\/jco.2013.31.15_suppl.4137","article-title":"A\u00a0multitranscript blood neuroendocrine tumor molecular signature to identify treatment efficacy and disease progress","volume":"31","author":"Modlin","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib208","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/1471-2407-14-564","article-title":"Blood transcript analysis and metastatic recurrent small bowel carcinoid management","volume":"14","author":"Modlin","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib209","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1530\/ERC-14-0190","article-title":"A\u00a0multianalyte PCR blood test outperforms single analyte ELISAs for neuroendocrine tumor detection","volume":"21","author":"Modlin","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib210","doi-asserted-by":"crossref","first-page":"e63364","DOI":"10.1371\/journal.pone.0063364","article-title":"The identification of gut\u00a0neuroendocrine tumor disease by multiple synchronous transcript analysis in blood","author":"Modlin","year":"2013","journal-title":"PloS ONE"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib211","first-page":"419","article-title":"Gut neuroendocrine tumor blood qPCR fingerprint assay: characteristics and reproducibility","volume":"52","author":"Modlin","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/EC-14-0100","article-title":"A\u00a0PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by PPIs","volume":"3","author":"Modlin","year":"2014","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jcmgh.2014.12.008_bib213","doi-asserted-by":"crossref","first-page":"D808","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9.1: protein-protein interaction networks, with increased coverage and integration","volume":"41","author":"Franceschini","year":"2013","journal-title":"Nucleic Acids Res"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X15000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X15000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T15:59:28Z","timestamp":1650988768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X15000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":213,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2352345X15000326"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2014.12.008","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2014.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}